Updates of Progestogens in Preterm Labour Review
Abstract
Preterm births (PTBs) are among the main source for feto-maternal mortality and short and long term neonatal/infant morbidity around the world. PTBs refer to premature deliveries occurring preceding 259 days of gestation or before 37 gestational weeks (gw).
This condition is prevalent and thusly presents a significant world general medical issue: It has been accounted for that roughly 15 million preterm deliveries universally in 2010, of which 1 million babies died because of PTB related complications. The biological bases and pathways of preterm delivery have just been to some extent clarified. PTB is a complex syndrome and inadequate exploration has been performed on the aetiology.
Many are the possible risk factors (past PTB, cervical effacement and dilatation, infections/inflammations being the major predisposing factors). Predictive, preventive and interventional procedures are expanding to manage patients at high risk for preterm delivery hence improving feto-neonatal results. Progesterone plays a critical part in the upkeep of uterine quiescence (particularly during the latter half of pregnancy) because of the constraint of stimulatory prostaglandin production and contraction related protein gene expression, the suppression of the inflammatory cascade activation and in this manner the spread of ascending infection, the decrease of cervical stroma degradation and gap-junction formation. Also, term and preterm labour onset are related with functional withdrawal of progesterone activity at a uterine level. As a result, progesterone and different progestogens have been tried in clinical preliminaries for preventing PTB. The characteristics of progestogens' pharmacokinetic and pharmacodynamics profile are of extraordinary interest to researchers and clinicians to characterize the ideal medication, route of administration, dosage and exposure-response relationship.
Keywords
Full Text:
PDFReferences
-Steer, Philip. "The epidemiology of preterm labour." BJOG: An International Journal of Obstetrics & Gynaecology 112 (2005): 1-3.
-Wen, Shi Wu, et al. "Epidemiology of preterm birth and neonatal outcome." Seminars in Fetal and Neonatal Medicine. Vol. 9. No. 6. WB Saunders, 2004.
- Kuehn, Bridget M. "Groups take aim at US preterm birth rate." Jama 296.24 (2006): 2907-2908.
- Tracy, S. K., et al. "Spontaneous preterm birth of liveborn infants in women at low risk in Australia over 10 years: a population‐based study." BJOG: An International Journal of Obstetrics & Gynaecology 114.6 (2007): 731-735.
- Blondel, B., et al. "General obstetrics: Preterm birth and multiple pregnancy in European countries participating in the PERISTAT project." BJOG: An International Journal of Obstetrics & Gynaecology 113.5 (2006): 528-535.
- McCormick, Marie C., and Douglas K. Richardson. "Premature infants grow up." (2002): 197-198.
- Saigal, Saroj, and Lex W. Doyle. "An overview of mortality and sequelae of preterm birth from infancy to adulthood." The Lancet 371.9608 (2008): 261-269.
- Hamilton, B. E., J. A. Martin, and S. J. Ventura. "Births: preliminary data for Natl Vital Stat Rep. 2007." (2006).
- Druckmann, René, and Marc-Alexandre Druckmann. "Progesterone and the immunology of pregnancy." The Journal of steroid biochemistry and molecular biology 97.5 (2005): 389-396.
- Szekeres-Bartho, Julia, et al. "Progesterone as an immunomodulatory molecule." International immunopharmacology 1.6 (2001): 1037-1048.
- Di Renzo, Gian Carlo, et al. "Progesterone in normal and pathological pregnancy." Hormone Molecular Biology and Clinical Investigation 27.1 (2016): 35-48.
- Schwartz, Nadav, et al. "Progesterone suppresses the fetal inflammatory response ex vivo." American journal of obstetrics and gynecology 201.2 (2009): 211-e1.
- Fanchin, Renato, et al. "Hormonal influence on the uterine contractility during ovarian stimulation." Human Reproduction 15. suppl_1 (2000): 90-100.
- Perusquı́a, Mercedes, and Jaime Jasso-Kamel. "Influence of 5α-and 5β-reduced progestin’s on the contractility of isolated human myometrium at term." Life sciences 68.26 (2001): 2933-2944.
- Chanrachakul, Boonsri, et al. "Progesterone enhances the tocolytic effect of ritodrine in isolated pregnant human myometrium." American journal of obstetrics and gynecology 192.2 (2005): 458-463.
- Liu, Jin, et al. "The effects of progesterone on apoptosis in the human trophoblast-derived HTR-8/SV neo cells." Molecular human reproduction 13.12 (2007): 869-874.
- Czajkowski, Krzysztof, et al. "Uteroplacental circulation in early pregnancy complicated by threatened abortion supplemented with vaginal micronized progesterone or oral dydrogesterone." Fertility and sterility 87.3 (2007): 613-618.
- Raghupathy, Raj, et al. "Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage." BJOG: An International Journal of Obstetrics & Gynaecology 112.8 (2005): 1096-1101.
- Hudić, Igor, et al. "Dydrogesterone supplementation in women with threatened preterm delivery—the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor." Journal of reproductive immunology 92.1-2 (2011): 103-107.
- Hung, Tai-Ho, et al. "Micronized progesterone pre-treatment affects the inflammatory response of human gestational tissues and the cervix to lipopolysaccharide stimulation." Placenta 57 (2017): 1-8.
- Ruddock, Nicole K., et al. "Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions." American journal of obstetrics and gynecology 199.4 (2008): 391-e1.
- KEIRSE, MARC JNC. "Progestogen administration in pregnancy may prevent preterm delivery." BJOG: An International Journal of Obstetrics & Gynaecology 97.2 (1990): 149-154.
- Nold, Christopher, et al. "Prevention of preterm birth by progestational agents: what are the molecular mechanisms?" American journal of obstetrics and gynecology 208.3 (2013): 223-e1.
- Maher, Mohammad Ahmed, et al. "Prevention of preterm birth: a randomized trial of vaginal compared with intramuscular progesterone." Acta obstetricia et gynecologica Scandinavica 92.2 (2013): 215-222.
- Meis, Paul J., et al. "Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate." New England Journal of Medicine 348.24 (2003): 2379-2385.
- Markham, Kara B., et al. "Preterm birth rates in a prematurity prevention clinic after adoption of progestin prophylaxis." Obstetrics & Gynecology 123.1 (2014): 34-39.
- Nahoul, K., L. Dehennin, and R. Scholler. "Radioimmunoassay of plasma progesterone after oral administration of micronized progesterone." Journal of steroid biochemistry 26.2 (1987): 241-249.
- Fitzpatrick, Lorraine A., and Andrew Good. "Micronized progesterone: clinical indications and comparison with current treatments." Fertility and sterility 72.3 (1999): 389-397.
- Di Renzo, G. C., et al. "The changing role of progesterone in preterm labour." BJOG: An International Journal of Obstetrics & Gynaecology 112 (2005): 57-60.
- Nelson, David B., et al. "17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study." American journal of obstetrics and gynecology 216.6 (2017): 600-e1.
- Rebarber, Andrei, et al. "Increased incidence of gestational diabetes in women receiving prophylactic 17α-hydroxyprogesterone caproate for prevention of recurrent preterm delivery." Diabetes care 30.9 (2007): 2277-2280.
- Bulletti, Carlo, et al. "Targeted drug delivery in gynaecology: the first uterine pass effect." Human Reproduction (Oxford, England) 12.5 (1997): 1073-1079.
- Zipori, Yaniv, et al. "Vaginal progesterone for the prevention of preterm birth and the risk of gestational diabetes." European Journal of Obstetrics & Gynecology and Reproductive Biology 230 (2018): 6-9.
- Afridi, Nighat, et al. "Comparison of efficacy of oral progesterone and micronized progesterone pessary in reduction of incidence of spontaneous preterm births." Journal of Ayub Medical College Abbottabad 31.2 (2019): 248-251.
- Elder, D. E., et al. "Hospital admissions in the first year of life in very preterm infants." Journal of paediatrics and child health 35.2 (1999): 145-150.
- Abdali, Fatemeh, et al. "Effect of progesterone on latent phase prolongation in patients with preterm premature rupture of membranes." Acta Medica Iranica (2017): 772-778.
- Quist-Nelson, Johanna, et al. "Progestogens in singleton gestations with preterm prelabor rupture of membranes: a systematic review and metaanalysis of randomized controlled trials." American journal of obstetrics and gynecology 219.4 (2018): 346-355.
- Kamat, S., P. Veena, and R. Rani. "Comparison of nifedipine and progesterone for maintenance tocolysis after arrested preterm labour." Journal of Obstetrics and Gynaecology 34.4 (2014): 322-325.
- Di Renzo, Gian Carlo, et al. "Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth." The Journal of Maternal-Fetal & Neonatal Medicine 24.5 (2011): 659-667.
- GOLDSTEIN, PETER, et al. "A meta‐analysis of randomized control trials of progestational agents in pregnancy." BJOG: An International Journal of Obstetrics & Gynaecology 96.3 (1989): 265-274.
- Di Renzo, Giancarlo C., et al. "Preterm labor and birth management: recommendations from the European Association of Perinatal Medicine." The Journal of Maternal-Fetal & Neonatal Medicine 30.17 (2017): 2011-2030.
- Blackwell, Sean C., et al. "17-OHPC to prevent recurrent preterm birth in singleton gestations (PROLONG study): a multicenter, international, randomized double-blind trial." American journal of perinatology 37.02 (2020): 127-136.
- Jarde, Alexander, et al. "Vaginal progesterone, oral progesterone, 17‐OHPC, cerclage, and pessary for preventing preterm birth in at‐risk singleton pregnancies: an updated systematic review and network meta‐analysis." BJOG: An International Journal of Obstetrics & Gynaecology 126.5 (2019): 556-567.
- Kuon, Ruben-J., Pauline Voß, and Werner Rath. "Progesterone for the prevention of preterm birth–an update of evidence-based indications." Geburtshilfe und Frauenheilkunde 79.08 (2019): 844-853.
- Schuit, E., et al. "Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta‐analysis." BJOG: An International Journal of Obstetrics & Gynaecology 122.1 (2015): 27-37.
- Dodd, Jodie M., et al. "Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy." Cochrane Database of Systematic Reviews 10 (2017).
- Romero, Roberto, et al. "Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta‐analysis of individual patient data." Ultrasound in Obstetrics & Gynecology 49.3 (2017): 303-314.
- Ashraf, Bushra. "Efficacy and safety of oral nifedipine with or without vaginal progesterone in the management of threatened preterm labor." International Journal of Reproductive BioMedicine 17.9 (2019): 629.
- Rath, Werner, and Ruben-J. Kuon. "Progesterone–Effective for Tocolysis and Maintenance Treatment After Arrested Preterm Labour?" Geburtshilfe und Frauenheilkunde 79.08 (2019): 834-843.
- Melcer, Yaakov, et al. "Arabin cervical pessary with vaginal progesterone versus vaginal progesterone for preventing preterm delivery." The Journal of Maternal-Fetal & Neonatal Medicine 33.20 (2020): 3439-3444.
- Shor, Shimrit, et al. "Combined therapy with vaginal progesterone, Arabin cervical pessary and cervical cerclage to prevent preterm delivery in high-risk women." The Journal of Maternal-Fetal & Neonatal Medicine 34.13 (2021): 2154-2158.
- Zimerman, Ariel, et al. "Prevention of preterm birth in twins with short mid-trimester cervical length less than 25mm-combined treatment with arabin's cerclage pessary and intravaginal micronized progesterone compared with conservative treatment." Harefuah 157.5 (2018): 301-304.
DOI: http://dx.doi.org/10.52155/ijpsat.v29.1.3686
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Maged Naser, Mohamed M. Naser, Lamia H. Shehata
This work is licensed under a Creative Commons Attribution 4.0 International License.